
Venture capital · Early stage · Est. 1992
MPM BioImpact
Boston-based biotech investment firm that builds and funds drug-development companies, investing in both private and public markets. It pairs venture-style company creation with impact-focused public equity funds.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is MPM BioImpact right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.
Latest investments
Rounds MPM BioImpact joined, from press and the firm’s own posts.
Every round MPM BioImpact joined
Round sizes, MPM BioImpact’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company MPM BioImpact backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet MPM BioImpact
Events where MPM BioImpact’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
MPM BioImpact is based in Boston, United States.
In 1992.
14 fund vehicles are on public registers (SEC adviser filings), including ONCOLOGY IMPACT FUND 2, L.P., UBS ONCOLOGY IMPACT FUND L.P. and MPM BIOVENTURES 2018, L.P.
Stages: Seed. Sectors: Biotech, Life sciences. From the firm’s own website.
The firm builds and backs biotech companies across the full drug development process, from seed to follow-on, aiming to turn scientific breakthroughs into medicines. Entrepreneur Partners with deep domain and regulatory expertise help create and lead portfolio companies, with an impact-oriented approach. From the firm’s own website.
MPM BioImpact lists 22 portfolio companies on its website, including Aktis, Arialys, AshiBio, AstronauTx and Crossbow Therapeutics.
Firms whose websites list some of the same companies include Agent Capital, Atlas Venture and Catalio Capital Management.
Know before MPM BioImpact’s next round is announced.
PRO tracks MPM BioImpact’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.